Stemirna Therapeutics
RNA technology based drug development company designed to maximize the potential of RNA science.
Launch date
Employees
Market cap
-
Enterprise valuation
$825m (Public information from May 2023)
Shanghai Shanghai (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
* | N/A | N/A | Angel |
* | N/A | N/A | Seed |
| N/A | $14.2m | Series A | |
* | $1.4m | Seed | |
* | N/A | Series B | |
$200m | Late VC | ||
* | N/A | CNY200m Valuation: CNY6.0b | Late VC |
| Total Funding | $243m | ||